FDA on Monday (Nov. 25) announced a series of steps to spur development of new ways to sterilize medical devices that don’t rely on ethylene oxide, including a voluntary pilot program under which companies that use ethylene oxide would submit a master file when changing locations or sterilization processes. The closure of multiple ethylene oxide producing sites due to high levels of ethylene oxide emissions has led the agency to look into alternatives to prevent a future shortage of essential...